Only 28% of ACOs formed in 2012 have taken on downside risk, while just 33% had at least one contract with downside risk in 2018, according to a study published in Health Affairs.

President Trump is preparing to issue an executive order that would declare a favored nations clause for drug prices, ensuring the U.S. would not pay higher prices than other countries for prescription medications, CNBC reported.

The biggest challenge to the Affordable Care Act to date heads to the 5th U.S. Circuit Court of Appeals in New Orleans Tuesday, July 9, for scheduled oral arguments in the case.

A federal judge has blocked the Trump administration’s rule requiring drugmakers to publish the list prices of prescription medications in direct-to-consumer television advertisements.

The economic cost of the of lost earnings due to cancer deaths in the U.S. was more than $94 billion in 2015, according to a new study published in JAMA Oncology.

While general support for a universal healthcare system remains at about 50% among the public, the impact to the healthcare industry is being weighed––and providers could see huge payment cuts under certain policies. 

Patients are worried about the rising cost of prescription drugs, and the high rate of cost growth has led lawmakers and the Trump administration to review steps to reduce runaway price growth. However, there are some ways for doctors to help patients avoid sticker shock on their prescriptions––and not many are using these tools, according to a report from NPR.

Five states have voiced they want to testify at an upcoming July hearing in the ongoing court review of the $69 billion CVS Health acquisition of Aetna.